With the Senate’s confirmation of Alvaro Bedoya to the Federal Trade Commission on May 11, Democrats now have a 3-2 majority in the FTC, which will likely lead to heightened scrutiny of competition in healthcare, Paul Keckley, PhD, wrote May 16 in The Keckley Report.
Read the full post on Becker's Hospital Review - Healthcare News
